EV/EBIT společnosti GAIN Capital

Jaká je hodnota metriky EV/EBIT společnosti GAIN Capital?

Hodnota metriky EV/EBIT společnosti GAIN Capital Holdings, Inc. je 2.51

Jaká je definice metriky EV/EBIT?

Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.

ttm (trailing twelve months)

The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:

Enterprise value = market cap + total debt – cash and cash equivalents

The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.

Čemu se věnuje společnost GAIN Capital?

GAIN Capital Holdings, Inc. engages in the provision of online trading services and solutions, specializing in over-the-counter and exchange-traded markets. It operates through the following segments: Retail and Futures. The Retail segment provides its retail customers around the world with access to a range global financial markets, including spot foreign exchange, precious metals trading, and contracts for difference. The Futures segment includes exchange-traded futures and options on futures on various global exchanges. This segment offers futures services through its subsidiary, GAIN Capital Group, LLC, under the GAIN Capital Futures brand. The company was founded by Mark E. Galant in October 1999 and is headquartered in Bedminster, NJ.

Firmy s metrikou ev/ebit podobnou společnosti GAIN Capital